127 related articles for article (PubMed ID: 28366834)
1. The Wilms tumor protein WT1 stimulates transcription of the gene encoding insulin-like growth factor binding protein 5 (IGFBP5).
Müller M; Persson AB; Krueger K; Kirschner KM; Scholz H
Gene; 2017 Jul; 619():21-29. PubMed ID: 28366834
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene
Kirschner KM; Sciesielski LK; Krueger K; Scholz H
J Biol Chem; 2017 Dec; 292(49):20281-20291. PubMed ID: 29042436
[TBL] [Abstract][Full Text] [Related]
3. WT1 regulates HOXB9 gene expression in a bidirectional way.
Schmidt V; Sieckmann T; Kirschner KM; Scholz H
Biochim Biophys Acta Gene Regul Mech; 2021; 1864(11-12):194764. PubMed ID: 34508900
[TBL] [Abstract][Full Text] [Related]
4. The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene.
Kirschner KM; Wagner N; Wagner KD; Wellmann S; Scholz H
J Biol Chem; 2006 Oct; 281(42):31930-9. PubMed ID: 16920711
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.
Pérez-Casellas LA; Wang X; Howard KD; Rehage MW; Strong DD; Linkhart TA
Biochim Biophys Acta; 2009 Feb; 1789(2):78-87. PubMed ID: 18809517
[TBL] [Abstract][Full Text] [Related]
6. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor protein (-KTS) modulates renin gene transcription.
Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene.
Dame C; Kirschner KM; Bartz KV; Wallach T; Hussels CS; Scholz H
Blood; 2006 Jun; 107(11):4282-90. PubMed ID: 16467207
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
11. A new role for wilms tumor protein 1: differential activities of + KTS and -KTS variants to regulate LHβ transcription.
Bagchi D; Andrade J; Shupnik MA
PLoS One; 2015; 10(1):e0116825. PubMed ID: 25617744
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation by the Wilms tumor protein, Wt1, suggests a role of the metalloproteinase Adamts16 in murine genitourinary development.
Jacobi CL; Rudigier LJ; Scholz H; Kirschner KM
J Biol Chem; 2013 Jun; 288(26):18811-24. PubMed ID: 23661704
[TBL] [Abstract][Full Text] [Related]
13. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
14. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
Idelman G; Glaser T; Roberts CT; Werner H
J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
16. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
17. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.
Hartwig S; Ho J; Pandey P; Macisaac K; Taglienti M; Xiang M; Alterovitz G; Ramoni M; Fraenkel E; Kreidberg JA
Development; 2010 Apr; 137(7):1189-203. PubMed ID: 20215353
[TBL] [Abstract][Full Text] [Related]
19. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.
Lee SB; Huang K; Palmer R; Truong VB; Herzlinger D; Kolquist KA; Wong J; Paulding C; Yoon SK; Gerald W; Oliner JD; Haber DA
Cell; 1999 Sep; 98(5):663-73. PubMed ID: 10490105
[TBL] [Abstract][Full Text] [Related]
20. Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.
Kirschner KM; Braun JF; Jacobi CL; Rudigier LJ; Persson AB; Scholz H
J Biol Chem; 2014 Aug; 289(35):24452-62. PubMed ID: 25037221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
